Showing results (581-590 of 1,751) with videos related to
Sort By:
Pageof 176
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Detailed analysis of IFNg response upon activation permits efficient isolation of cytomegalovirus-specific CD8+ T cells for adoptive immunotherapyMaarten L Zandvliet, J H Frederik Falkenburg, Inge Jedema, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gammaIlka Knippertz, Andrea Hesse, Tanja Schunder, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Development of an Escherichia coli expressing listeriolysin-O vaccine against Wilms tumor gene 1-expressing tumorsMing-Shen Dai, Josianne Nitcheu-Tefit, Sally Alcock, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Genome-wide mapping of PiggyBac transposon integrations in primary human T cellsDaniel L Galvan, Yozo Nakazawa, Aparna Kaja, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Optimization of the PiggyBac transposon system for the sustained genetic modification of human T lymphocytesYozo Nakazawa, Leslie E Huye, Gianpietro Dotti, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumorsRafal Zielinski, Ilya Lyakhov, Amy Jacobs, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
IRF9 is a key factor for eliciting the antiproliferative activity of IFN-alphaTakaya Tsuno, Josef Mejido, Tongmao Zhao, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 16, 2009
Local AdCD40L gene therapy is effective for disseminated murine experimental cancer by breaking T-cell tolerance and inducing tumor cell growth inhibitionCamilla Lindqvist, Linda C Sandin, Moa Fransson, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Combinational therapy of interferon-α and chemotherapy normalizes tumor vasculature by regulating pericytes including the novel marker RGS5 in melanomaPian Liu, Chen Zhang, Jing Chen, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 11, 2011
Modulation of NKG2D-ligand cell surface expression enhances immune cell therapy of cancerBaocheng Huang, Rachel Sikorski, Padma Sampath, et al.Pageof 176